SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-030152
Filing Date
2022-11-02
Accepted
2022-11-02 08:00:16
Documents
13
Period of Report
2022-11-01
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43767
2 ex3-1.htm EX-3.1 12741
  Complete submission text file 0001493152-22-030152.txt   236013

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vynt-20221101.xsd EX-101.SCH 3227
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vynt-20221101_lab.xml EX-101.LAB 34240
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vynt-20221101_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3816
Mailing Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002
Business Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002 201.528.9200
Vyant Bio, Inc. (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 221352332
SIC: 8071 Services-Medical Laboratories